These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8408658)

  • 1. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
    Wei CM; Kim CH; Miller VM; Burnett JC
    J Clin Invest; 1993 Oct; 92(4):2048-52. PubMed ID: 8408658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
    Wei CM; Kim CH; Khraibi AA; Miller VM; Burnett JC
    Hypertension; 1994 Jun; 23(6 Pt 2):903-7. PubMed ID: 8206626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].
    Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT
    Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries.
    Woodard GE; Li X; Brown J; Rosado JA
    Regul Pept; 2005 Jul; 129(1-3):183-9. PubMed ID: 15927715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of C-type natriuretic peptide in isolated canine arteries and veins.
    Wei CM; Aarhus LL; Miller VM; Burnett JC
    Am J Physiol; 1993 Jan; 264(1 Pt 2):H71-3. PubMed ID: 8430863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vasonatrin peptide on random pattern skin flap survival.
    Wang SP; Lan ZY; Xia W; Zhao X; Ma GJ; Liu B; Pan BH; Guo SZ
    Ann Plast Surg; 2014 Jan; 72(1):94-9. PubMed ID: 23403542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions.
    Chen BY; Chen JK; Zhu MZ; Zhang DL; Sun JS; Pei JM; Feng HS; Zhu XX; Jin J; Yu J
    PLoS One; 2011; 6(5):e20477. PubMed ID: 21647224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type natriuretic peptide: a selective cardiovascular peptide.
    Clavell AL; Stingo AJ; Wei CM; Heublein DM; Burnett JC
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R290-5. PubMed ID: 8383462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new natriuretic peptide isolated from cardiac atria of trout, Oncorhynchus mykiss.
    Takei Y; Fukuzawa A; Itahara Y; Watanabe TX; Yoshizawa Kumagaye K; Nakajima K; Yasuda A; Smith MP; Duff DW; Olson KR
    FEBS Lett; 1997 Sep; 414(2):377-80. PubMed ID: 9315723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries.
    Barber DA; Burnett JC; Fitzpatrick LA; Sieck GC; Miller VM
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):5-11. PubMed ID: 9676714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells.
    Furuya M; Takehisa M; Minamitake Y; Kitajima Y; Hayashi Y; Ohnuma N; Ishihara T; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1990 Jul; 170(1):201-8. PubMed ID: 2164803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue.
    Protter AA; Wallace AM; Ferraris VA; Weishaar RE
    Am J Hypertens; 1996 May; 9(5):432-6. PubMed ID: 8735173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor proteins and biological effects of C-type natriuretic peptides in the renal glomerulus of the rat.
    Brown J; Zuo Z
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1383-94. PubMed ID: 8184983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure and function of ventricular natriuretic peptide (VNP)].
    Takei Y
    Nihon Rinsho; 1992 Mar; 50(3):656-63. PubMed ID: 1534127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the C-terminal region of rat brain natriuretic peptide in receptor selectivity.
    Shimekake Y; Kawabata T; Nakamura M; Nagata K
    FEBS Lett; 1992 Sep; 309(2):185-9. PubMed ID: 1324196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats].
    Dong MQ; Zhu MZ; Yu J; Shang LJ; Feng HS
    Sheng Li Xue Bao; 2000 Jun; 52(3):252-4. PubMed ID: 11956575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the suppressive actions on intestinal absorption and on cGMP production for the natriuretic peptide family in dogs.
    Kagawa K; Suzuki S; Matsushita K; Uemura N; Morita H; Hosomi H
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):83-92. PubMed ID: 8039275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.